Title of article
Diabetic Macular Edema
Author/Authors
Gundogan, Fatih C. GATA Medical School - Ophthalmology , Yolcu, Umit Sarikamis Military Hospital - Ophthalmology , Akay, Fahrettin İzmir Military Hospital - Ophthalmology , Ilhan, Abdullah Erzurum Military Hospital - Ophthalmology , Ozge, Gokhan GATA Medical School - Ophthalmology , Uzun, Salih Etimesgut Military Hospital - Ophthalmology
Pages
6
From page
505
To page
510
Abstract
Diabetic macular edema (DME), one the most prevalent causes of visual loss in industrialized countries,
may be diagnosed at any stage of diabetic retinopathy. The diagnosis, treatment, and follow up of DME
have become straightforward with recent developments in fundus imaging, such as optical coherence
tomography. Laser photocoagulation, intravitreal injections, and pars plana vitrectomy surgery are the
current treatment modalities; however, the positive effects of currently available intravitreally injected
agents are temporary. At this point, further treatment choices are needed for a permanent effect.
Sources of data selection: The articles published between 1985-2015 years on major databases were
searched and most appropriate 40 papers were used to write this review article.
Keywords
Pars plana vitrectomy , Triamcinolone acetonide , Bevacizumab , Fluorescein angiography , Optical coherence tomography , Diabetic macular edema , Ranibizumab
Journal title
Astroparticle Physics
Serial Year
2016
Record number
2422920
Link To Document